Uterine Corpus Carcinosarcoma: Clinical Trials

7 trials for Uterine Corpus Carcinosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 1 terminated. 3 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Not applicable1Recruiting 1
Phase 11Completed 1
Phase 31Recruiting 1

Follow Uterine Corpus Carcinosarcoma: new trials by email Literature Review of Uterine Corpus Carcinosarcoma trials Research Report on Uterine Corpus Carcinosarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Best Practice, Interview, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableRecruitingCity of Hope Medical Center1262026-09-092026-10-16
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Biospecimen Collection, Liquid Biopsy, Pap Smear - Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma
RecruitingM.D. Anderson Cancer Center10002019-06-182026-10-07
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
Vaginal Cuff Brachytherapy, Short course vaginal cuff brachytherapy - Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma
Phase 3RecruitingUniversity of Utah1882018-02-022025-12-12
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Metformin Hydrochloride, Doxycycline - Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University292016-06-082026-04-22
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers
Bevacizumab, Laboratory Biomarker Analysis, Nab-paclitaxel - Cervical Adenocarcinoma, Cervical Adenosarcoma
Phase 1CompletedMayo Clinic432014-02-242024-07-26
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Cabozantinib S-malate, Laboratory Biomarker Analysis, Pharmacological Study - Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2CompletedNational Cancer Institute (NCI)1022013-05-082025-10-01
Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Sunitinib Malate - Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma
Phase 2CompletedNational Cancer Institute (NCI)342007-04-302020-02-17

Narrower conditions

Breast Neoplasms (2)  ·  Carcinoma, Endometrioid (1)  ·  Endometrial Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)  ·  Uterine Neoplasms (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Adnexal Diseases (2)  ·  Breast Diseases (2)  ·  Endocrine System Diseases (2)  ·  Gonadal Disorders (2)  ·  Ovarian Diseases (2)  ·  Skin Diseases (2)

Interventions

Practice Guidelines as Topic (2)  ·  Standard of Care (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Bevacizumab (1)  ·  Brachytherapy (1)  ·  Disulfides (1)  ·  Doxycycline (1)  ·  Immunoglobulin G (1)  ·  Interviews as Topic (1)  ·  Liquid Biopsy (1)  ·  Metformin (1)  ·  Palliative Care (1)  ·  Papanicolaou Test (1)  ·  Sunitinib (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  City of Hope Medical Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  University of Utah (1)

Countries

United States (7)  ·  Canada (2)

Top investigators

Amit M Oza (1)  ·  Anne Reb (1)  ·  Cristina DeCesaris, MD (1)  ·  Jennifer Johnson, MD, PhD (1)  ·  Matthew S. Block, M.D., Ph.D. (1)  ·  Neesha Dhani (1)  ·  Pamela T Soliman (1)

Results publications

PMID 24882554, PMID 31992589

NIH funding

N01CM00032 (1), N01CM00038 (1), N01CM00071 (1), N01CM62201 (1), N01CM62203 (1), N01CM62209 (1), P30CA033572 (1), R21CA293326 (1), UM1CA186644 (1)